ESC 365 - Identifying a cardioprotective agent using human quadricellular cardiovascular organoids for modelling chemotherapy-induced cardiomyopathy.

HFA Premium Access

Identifying a cardioprotective agent using human quadricellular cardiovascular organoids for modelling chemotherapy-induced cardiomyopathy.

Session: Chronic heart failure - pathophysiology and mechanisms 2

Topic: Cardiotoxicity of Drugs and Other Therapies

Speaker: Ms C. Bashai (Haifa, IL)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Ms Caroline Bashai

Technion - Israel Institute of Technology, Haifa (Israel)

0 follower

6 more presentations in this session

Selective endothelin type A receptor blockade attenuates high-output heart failure induced by aorto-caval fistula and renal impairment induced by 5/6 nephrectomy in rats.

Speaker: Doctor P. Kala (Prague, CZ)

Pharmacokinetics of stress hormones and the importance of body temperature in the development of the Takotsubo Syndrome

Speaker: Mr E. Zulfaj (Gothenburg, SE)

Renal denervation normalizes norepinephrine signaling in the left ventricle in rat model of heart failure due to volume overload

Speaker: Mr M. Miklovic (Prague, CZ)

Impact of Cytokine Release Syndrome on Cardiac Function in Patients with Chimeric Antigen Receptor-T Therapy

Speaker: Doctor I. Sunayama (Nishinomiya, JP)

Mitochondrial dynamics and myocardial metabolism alterations during anthracycline-cardiotoxicity

Speaker: Miss A. Diaz-Guerra Priego (Madrid, ES)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 2

Speakers: Ms C. Bashai, Doctor P. Kala, Mr E. Zulfaj, Mr M. Miklovic, Doctor I. Sunayama...

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources